Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 90

1.

Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.

Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, Walter LC, Church TR, Flowers CR, LaMonte SJ, Wolf AM, DeSantis C, Lortet-Tieulent J, Andrews K, Manassaram-Baptiste D, Saslow D, Smith RA, Brawley OW, Wender R; American Cancer Society.

JAMA. 2015 Oct 20;314(15):1599-614. doi: 10.1001/jama.2015.12783. Erratum in: JAMA. 2016 Apr 5;315(13):1406.

2.

The role of communication in breast cancer screening: a qualitative study with Australian experts.

Parker LM, Rychetnik L, Carter SM.

BMC Cancer. 2015 Oct 19;15:741. doi: 10.1186/s12885-015-1749-0.

3.

Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer.

Afghahi A, Forgó E, Mitani AA, Desai M, Varma S, Seto T, Rigdon J, Jensen KC, Troxell ML, Gomez SL, Das AK, Beck AH, Kurian AW, West RB.

Breast Cancer Res. 2015 Aug 13;17:108. doi: 10.1186/s13058-015-0623-y.

4.

Regional-Level Correlations in Inappropriate Imaging Rates for Prostate and Breast Cancers: Potential Implications for the Choosing Wisely Campaign.

Makarov DV, Soulos PR, Gold HT, Yu JB, Sen S, Ross JS, Gross CP.

JAMA Oncol. 2015 May;1(2):185-94. doi: 10.1001/jamaoncol.2015.37.

5.

What do you think overdiagnosis means? A qualitative analysis of responses from a national community survey of Australians.

Moynihan R, Nickel B, Hersch J, Doust J, Barratt A, Beller E, McCaffery K.

BMJ Open. 2015 May 19;5(5):e007436. doi: 10.1136/bmjopen-2014-007436.

6.

Emergency visits among end-of-life cancer patients in Taiwan: a nationwide population-based study.

Lee YH, Chu D, Yang NP, Chan CL, Cheng SP, Pai JT, Chang NT.

BMC Palliat Care. 2015 May 9;14:25. doi: 10.1186/s12904-015-0016-0.

7.

Bias in Observational Studies of the Association between Menopausal Hormone Therapy and Breast Cancer.

Zahl PH, Mæhlen J.

PLoS One. 2015 May 4;10(5):e0124076. doi: 10.1371/journal.pone.0124076. eCollection 2015.

8.

Benefits and harms of mammography screening.

Løberg M, Lousdal ML, Bretthauer M, Kalager M.

Breast Cancer Res. 2015 May 1;17:63. doi: 10.1186/s13058-015-0525-z. Review.

9.

Twenty-five years of breast cancer risk models and their applications.

Gail MH.

J Natl Cancer Inst. 2015 Feb 26;107(5). pii: djv042. doi: 10.1093/jnci/djv042. Print 2015 May. No abstract available.

10.

Perspectives on mammography after receipt of secondary screening owing to a false positive.

Thomson MD, Siminoff LA.

Womens Health Issues. 2015 Mar-Apr;25(2):128-33. doi: 10.1016/j.whi.2014.11.003. Epub 2015 Jan 31.

11.

Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods.

Carter JL, Coletti RJ, Harris RP.

BMJ. 2015 Jan 7;350:g7773. doi: 10.1136/bmj.g7773. Review.

12.

Granular cell tumor of the breast: a case report.

Hammas N, El Fatemi H, Jayi S, Hafid I, Fikri G, El Houari A, Seqqali N, Tizniti S, Melhouf MA, Amarti A.

J Med Case Rep. 2014 Dec 26;8:465. doi: 10.1186/1752-1947-8-465.

13.

Enthusiasm for cancer screening in Great Britain: a general population survey.

Waller J, Osborne K, Wardle J.

Br J Cancer. 2015 Feb 3;112(3):562-6. doi: 10.1038/bjc.2014.643. Epub 2014 Dec 23.

14.

A reality check for overdiagnosis estimates associated with breast cancer screening.

Etzioni R, Xia J, Hubbard R, Weiss NS, Gulati R.

J Natl Cancer Inst. 2014 Oct 31;106(12). pii: dju315. doi: 10.1093/jnci/dju315. Print 2014 Dec.

15.

Neurological complications of breast cancer: study protocol of a prospective cohort study.

Pereira S, Fontes F, Sonin T, Dias T, Fragoso M, Castro-Lopes J, Lunet N.

BMJ Open. 2014 Oct 28;4(10):e006301. doi: 10.1136/bmjopen-2014-006301.

16.

A survey study of women's responses to information about overdiagnosis in breast cancer screening in Britain.

Waller J, Whitaker KL, Winstanley K, Power E, Wardle J.

Br J Cancer. 2014 Oct 28;111(9):1831-5. doi: 10.1038/bjc.2014.482. Epub 2014 Aug 28.

17.

Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland.

Heinävaara S, Sarkeala T, Anttila A.

Br J Cancer. 2014 Sep 23;111(7):1463-8. doi: 10.1038/bjc.2014.413. Epub 2014 Aug 14.

18.

The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial.

Hersch J, Barratt A, Jansen J, Houssami N, Irwig L, Jacklyn G, Dhillon H, Thornton H, McGeechan K, Howard K, McCaffery K.

BMJ Open. 2014 May 15;4(5):e004990. doi: 10.1136/bmjopen-2014-004990.

19.

Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.

Onega T, Beaber EF, Sprague BL, Barlow WE, Haas JS, Tosteson AN, D Schnall M, Armstrong K, Schapira MM, Geller B, Weaver DL, Conant EF.

Cancer. 2014 Oct 1;120(19):2955-64. doi: 10.1002/cncr.28771. Epub 2014 May 15. Review.

20.

Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom.

Gunsoy NB, Garcia-Closas M, Moss SM.

Br J Cancer. 2014 May 13;110(10):2412-9. doi: 10.1038/bjc.2014.206. Epub 2014 Apr 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk